Teva Pharmaceutical Industries Ltd, ADR (TEVA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

5 BAZEL ST PETACH TIKVA, ISRAEL 49131

Teva Pharmaceutical Industries Ltd (Teva) is an Israel-based pharmaceutical and drug company. It develops, produces and markets generic drugs in all treatment categories. The Company has a pharmaceutical business, whose principal products include Copaxone and Azilect. Tevas active pharmaceutical ingredient (API) business provides vertical integration to Tevas own pharmaceutical production. The Companys global operations are conducted from North and Latin America to Europe and Asia. Teva operates a number of subsidiaries in such countries as Canada, Croatia, the Czech Republic, France, Germany, Hungary, Ireland, Israel, Japan, Poland, the Russian Federation, Spain, the Netherlands, the United Kingdom and the United States.

Data based on most recent fiscal year report
Market Cap17.236 Billion Shares Outstanding1.017 Billion Avg Volume25.904 Million
1-Yr BETA vs S&P TR Current Ratio0.86 Quick Ratio0.58
View SEC Filings from TEVA instead.
Q2 2019 All Institutions Hedge Funds 1
To trade TEVA now:
Filers who had this stock in their top 10: 6 3 (0.31%)
13F Filers holding this stock: 439 42 (4.34%)
Aggregate 13F shares on 06/30/2019: 631.479 Million 66.437 Million
Aggregate 13F shares on 03/31/2019: 661.851 Million 88.6 Million
Percent change: -4.59% -25.01%
Funds creating new positions: 46 8
Funds Adding to an existing position: 156 14
Funds closing out their position: 106 18
Funds reducing their position: 131 13
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

 

Teva Pharmaceutical Industries Ltd, ADR Chart by YCharts

Yahoo! Finance

finviz

Check out our reporting and analysis

Funds Holding TEVA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

6.7 Thousand total shares from 6 transactions

Exercise Derivative Conversion (M)

15 Thousand total shares from 7 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DRAPE ERIC EXECUTIVE VP GLOBAL OPERATIONS

  • Officer
 17,195 2019-10-02 1

DANIELL RICHARD EXEC. VP, EUROPEAN COMMERCIAL

  • Officer
 1,676 2019-09-18 6

DETHLEFS SVEN EVP GLOBAL MARKETING&PORTFOLIO

  • Officer
 10,595 2019-09-18 5

GRIFFIN DEBORAH A CHIEF ACCOUNTING OFFICER

  • Officer
 0 2019-09-18 5

MCCLELLAN MICHAEL JAMES EVP, CHIEF FINANCIAL OFFICER

  • Officer
 15,445 2019-09-18 5

NAZZI GIANFRANCO EVP, GROWTH MARKETS COMMERCIAL

  • Officer
 10,678 2019-09-18 5

O'GRADY BRENDAN P. EVP, NORTH AMERICA COMMERCIAL

  • Officer
 2,135 2019-09-18 5

CRANE ROSEMARY A

  • Director
 8,543 2019-08-22 2

BARER SOL J

  • Director
 0 2019-08-13 4

GREENE-SULZBERGER GABRIELLE

  • Director
 1,621 2019-06-25 0

ELSTEIN AMIR

  • Director
 0 2019-06-11 2

GOLDBERG MURRAY A

  • Director
 0 2019-06-11 1

HALFON JEAN MICHEL

  • Director
 0 2019-06-11 2

LIEBERMAN GERALD M

  • Director
 0 2019-06-11 2

MIGNONE ROBERTO

  • Director
 0 2019-06-11 1

NISEN PERRY

  • Director
 0 2019-06-11 1

PERES NECHEMIA JACOB

  • Director
 0 2019-06-11 1

SATCHI-FAINARO RONIT

  • Director
 0 2019-06-11 1

DE NOTARISTEFANI CARLO EXECUTIVE VP GLOBAL OPERATIONS

  • Officer
 33,589 2019-05-18 5

FRIDRIKSDOTTIR HAFRUN EXECUTIVE VP, GLOBAL R&D

  • Officer
 16,750 2019-03-17 6

STARK DAVID MATTHEW EXEC. VP CHIEF LEGAL OFFICER

  • Officer
 2,974 2019-03-17 4

SCHULTZ KARE PRESIDENT AND CEO

  • Officer
  • Director
 0 2019-03-04 1

CODNER IRIS BECK EVP GLOBAL BRAND&COMMUNICATION

  • Officer
 0 2019-03-04 3

SABAG MARK EVP, GLOBAL HUMAN RESOURCES

  • Officer
 0 2019-03-04 3

SUESSKIND DAN S

  • Director
 318,836 2018-01-19 0

MAOR GALIA

  • Director
 0 2018-01-01 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

O'GRADY BRENDAN P. - Officer EVP, NORTH AMERICA COMMERCIAL

2019-09-18 M 1,241 a 2,629 2,135.49 direct

NAZZI GIANFRANCO - Officer EVP, GROWTH MARKETS COMMERCIAL

2019-09-18 M 2,638 a 11,640 10,678.36 direct

MCCLELLAN MICHAEL JAMES - Officer EVP, CHIEF FINANCIAL OFFICER

2019-09-18 M 4,091 a 16,851 15,445.27 direct

GRIFFIN DEBORAH A - Officer CHIEF ACCOUNTING OFFICER

2019-09-18 M 2,376 a 2,376 0.00 direct

DANIELL RICHARD - Officer EXEC. VP, EUROPEAN COMMERCIAL

2019-09-18 M 2,489 d 0 1,676.00 direct

O'GRADY BRENDAN P. - Officer EVP, NORTH AMERICA COMMERCIAL

2019-09-18 M 1,241 d 0 2,135.49 direct

NAZZI GIANFRANCO - Officer EVP, GROWTH MARKETS COMMERCIAL

2019-09-18 M 2,638 d 0 10,678.36 direct

MCCLELLAN MICHAEL JAMES - Officer EVP, CHIEF FINANCIAL OFFICER

2019-09-18 M 4,091 d 0 15,445.27 direct

GRIFFIN DEBORAH A - Officer CHIEF ACCOUNTING OFFICER

2019-09-18 M 2,376 d 0 0.00 direct

DETHLEFS SVEN - Officer EVP GLOBAL MARKETING&PORTFOLIO

2019-09-18 M 1,446 d 0 10,594.70 direct

DANIELL RICHARD - Officer EXEC. VP, EUROPEAN COMMERCIAL

2019-09-18 S 1,176 $7.82 d 1,676 1,676.00 direct

O'GRADY BRENDAN P. - Officer EVP, NORTH AMERICA COMMERCIAL

2019-09-18 S 494 $7.83 d 2,135 2,135.49 direct

NAZZI GIANFRANCO - Officer EVP, GROWTH MARKETS COMMERCIAL

2019-09-18 S 962 $7.82 d 10,678 10,678.36 direct

MCCLELLAN MICHAEL JAMES - Officer EVP, CHIEF FINANCIAL OFFICER

2019-09-18 S 1,406 $7.83 d 15,445 15,445.27 direct yes

GRIFFIN DEBORAH A - Officer CHIEF ACCOUNTING OFFICER

2019-09-18 S 2,376 $7.83 d 0 0.00 direct

DETHLEFS SVEN - Officer EVP GLOBAL MARKETING&PORTFOLIO

2019-09-18 M 1,446 a 10,595 10,594.70 direct

DANIELL RICHARD - Officer EXEC. VP, EUROPEAN COMMERCIAL

2019-09-18 M 2,489 a 2,852 1,676.00 direct

DANIELL RICHARD - Officer EXEC. VP, EUROPEAN COMMERCIAL

2019-09-09 M 696 a 696 363.00 direct

DANIELL RICHARD - Officer EXEC. VP, EUROPEAN COMMERCIAL

2019-09-09 M 696 d 698 363.00 direct

DANIELL RICHARD - Officer EXEC. VP, EUROPEAN COMMERCIAL

2019-09-09 S 333 $7.16 d 363 363.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments